Not Yet Recruiting PHASE1/PHASE2 INTERVENTIONAL 2-arm
NCT07459959
LiO-AD: Lithium Orotate in Alzheimers Disease Feasibility, Biomarker Engagement, and Clinical Response (LiO-AD)
Sponsor: Johns Hopkins University
Conditions
Alzheimer s Disease
Interventions
Lithium orotate Matched Placebo (Capsules)
Updated 1 time since 2026 Last updated: Mar 4, 2026 Started: Jun 1, 2026 Primary completion: Jun 1, 2029 Completion: Aug 31, 2029
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.
This PHASE1/PHASE2 trial investigates Alzheimer s Disease and is currently actively recruiting participants. Johns Hopkins University leads this study, which shows 1 recorded version since 2026 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.
Status Flow
Change History
1 version recorded Not Yet Recruiting — PHASE1/PHASE2
[monthly]
Eligibility Summary
No eligibility information available.
Contact Information
Sponsor contact:
- Johns Hopkins University
- National Institutes of Health (NIH)
Data source: Johns Hopkins University
For direct contact, visit the study record on ClinicalTrials.gov .
Study Locations
No location information available.